Selection of Plasmodium falciparum pfmdr1 alleles following therapy with artemether-lumefantrine in an area of Uganda where malaria is highly endemic
about
Artemisinin-based combination therapies: a vital tool in efforts to eliminate malariaTemporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in UgandaTemporal trends in prevalence of Plasmodium falciparum drug resistance alleles over two decades of changing antimalarial policy in coastal KenyaPfMDR1: mechanisms of transport modulation by functional polymorphismsGenome wide adaptations of Plasmodium falciparum in response to lumefantrine selective drug pressureThe role of Pfmdr1 and Pfcrt in changing chloroquine, amodiaquine, mefloquine and lumefantrine susceptibility in western-Kenya P. falciparum samples during 2008-2011Molecular surveillance as monitoring tool for drug-resistant Plasmodium falciparum in Suriname.World Antimalarial Resistance Network (WARN) III: molecular markers for drug resistant malaria.Sulfadoxine-pyrimethamine-based combinations for malaria: a randomised blinded trial to compare efficacy, safety and selection of resistance in Malawi.Seasonal distribution of anti-malarial drug resistance alleles on the island of Sumba, Indonesia.In vitro sensitivities of Plasmodium falciparum to different antimalarial drugs in Uganda.In vitro interaction of lumefantrine and piperaquine by atorvastatin against Plasmodium falciparum.Molecular surveillance of Plasmodium falciparum resistance to artemisinin-based combination therapies in the Democratic Republic of Congo.Selection of known Plasmodium falciparum resistance-mediating polymorphisms by artemether-lumefantrine and amodiaquine-sulfadoxine-pyrimethamine but not dihydroartemisinin-piperaquine in Burkina FasoComparative impacts over 5 years of artemisinin-based combination therapies on Plasmodium falciparum polymorphisms that modulate drug sensitivity in Ugandan childrenDifferent mutation patterns of Plasmodium falciparum among patients in Jimma University Hospital, Ethiopia.Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine.Increased prevalence of the pfdhfr/phdhps quintuple mutant and rapid emergence of pfdhps resistance mutations at codons 581 and 613 in Kisumu, Kenya.Brazilian Plasmodium falciparum isolates: investigation of candidate polymorphisms for artemisinin resistance before introduction of artemisinin-based combination therapy.Return of chloroquine-sensitive Plasmodium falciparum parasites and emergence of chloroquine-resistant Plasmodium vivax in Ethiopia.Molecular assessment of Plasmodium falciparum resistance to antimalarial drugs in Papua New Guinea using an extended ligase detection reaction fluorescent microsphere assay.Limited ability of Plasmodium falciparum pfcrt, pfmdr1, and pfnhe1 polymorphisms to predict quinine in vitro sensitivity or clinical effectiveness in UgandaHigh prevalence of pfmdr1 N86Y and Y184F mutations in Plasmodium falciparum isolates from Bioko Island, Equatorial GuineaRole of Pfmdr1 in in vitro Plasmodium falciparum susceptibility to chloroquine, quinine, monodesethylamodiaquine, mefloquine, lumefantrine, and dihydroartemisininEffectiveness of artemether-lumefantrine provided by community health workers in under-five children with uncomplicated malaria in rural Tanzania: an open label prospective studyIn vivo selection of Plasmodium falciparum Pfcrt and Pfmdr1 variants by artemether-lumefantrine and dihydroartemisinin-piperaquine in Burkina Faso.Multiple genetic backgrounds of the amplified Plasmodium falciparum multidrug resistance (pfmdr1) gene and selective sweep of 184F mutation in CambodiaThe MSPDBL2 codon 591 polymorphism is associated with lumefantrine in vitro drug responses in Plasmodium falciparum isolates from Kilifi, KenyaIntrahost selection of Plasmodium falciparum pfmdr1 alleles after antimalarial treatment on the northwestern border of Thailand.Prolonged selection of pfmdr1 polymorphisms after treatment of falciparum malaria with artemether-lumefantrine in Uganda.Increased pfmdr1 copy number and sequence polymorphisms in Plasmodium falciparum isolates from Sudanese malaria patients treated with artemether-lumefantrine.Amodiaquine and artemether-lumefantrine select distinct alleles of the Plasmodium falciparum mdr1 gene in Tanzanian children treated for uncomplicated malaria.Molecular markers of anti-malarial drug resistance in southwest Ethiopia over time: regional surveillance from 2006 to 2013.In vivo antimalarial evaluation of some 2,3-disubstituted-4(3H)-quinazolinone derivatives.Resistance-mediating Plasmodium falciparum pfcrt and pfmdr1 alleles after treatment with artesunate-amodiaquine in UgandaA comparative study on the efficacy of artesunate plus sulphadoxine/pyrimethamine versus artemether-lumefantrine in eastern Sudan.Artesunate-Amodiaquine and Artemether-Lumefantrine Therapies and Selection of Pfcrt and Pfmdr1 Alleles in Nanoro, Burkina Faso.Molecular markers in plasmodium falciparum linked to resistance to anti-malarial drugs in samples imported from Africa over an eight-year period (2002-2010): impact of the introduction of artemisinin combination therapy.Alterations in Plasmodium falciparum genetic structure two years after increased malaria control efforts in western Kenya.Rational deployment of antimalarial drugs in Africa: should first-line combination drugs be reserved for paediatric malaria cases?
P2860
Q24614989-6994D46F-CD96-4E3F-BA44-4A6ABDA5A6ECQ28125904-FA9DDC2F-BA65-4441-A729-C3A9177F7CA9Q28125914-8701EEF7-AB10-45D7-BF28-A208FA508410Q28476753-DBB9D209-618B-48CF-97EB-BE252C3C9FA2Q28481274-4EFCEDD7-B4A0-47C1-AA8A-D3145C16FE87Q28487960-EC93A161-B273-416C-9DFA-70EE355AB6F3Q29353745-489F07FA-183B-4679-ACEE-B4707B2CFA10Q30483555-4E048D14-BDFB-4861-9552-4D849FECC15CQ33319559-47B8B7BD-3635-494A-A219-AF05B700F7B0Q33507449-5E5ECBC8-8DC2-4C5E-9B12-248D7D95BB53Q33676088-292C27AD-76C8-4D13-BE66-541D6D9F66FAQ33712676-29496C0C-921A-4D94-BB19-DD210CB98B23Q33778751-12E3D75E-A0BA-40E0-847A-1D442D1D58C9Q33826359-32F3DD14-4DFF-4DA5-9C48-6276EAB1B5D6Q33947834-DCFC6A89-9E21-44D4-A6E5-611CCD8FF310Q34068703-ABD104FF-F86F-4198-987E-A32C46922619Q34281680-47E78B84-FC59-4AE0-A39F-910BE0F52018Q34405184-26A6C145-EDDC-4CB5-9CF9-4661BC12EF0EQ34473796-102C139F-11A4-4B6C-AFE1-61050B1CE88EQ34504371-A6BD4FB0-7C93-46D1-8D2B-DB060A458975Q34529101-7A8FABE1-4682-4296-9D1C-AB0522362098Q34529355-4047A21E-6928-44A7-A7F1-5CBDCEF10911Q34562754-54995C0F-6C76-42F9-9826-4650442326DCQ34597550-10B6F9F6-7EB5-468B-8B3F-C685CDBDDE26Q34728230-9CD99F38-2F47-48E2-A63F-C54F04B7EA87Q34923315-BF6CD67B-3C88-409C-BC3A-6600492F4CA7Q34986023-DDB0FEFF-B8E5-431E-AB4A-A633D7593A9DQ35076843-D95184C6-FD6D-4978-9442-E264A2FFAF8AQ35112341-36906106-9065-42AB-A494-48DF715BD053Q35188480-455D9181-4ED0-4684-BF9F-F3308E2E1356Q35364589-57BEE36B-F74C-4E34-88EC-397E433B22EAQ35647706-4F820428-C28D-42C9-B766-D962CC4C679FQ35814367-B27EC7A7-F9CA-47DE-9232-C5D1B6B94A5CQ35815377-C150C17E-3F94-4538-9777-FFAAEA62A78CQ35912645-CB1492F6-F6F2-46B3-B0AF-FAD89CE7255DQ35925276-03C32769-0451-4683-8A16-167D0F37410BQ35975011-7E33CFF9-C3BE-4CD6-B623-AC523C2E3BF5Q36051104-BFADEE63-4C16-4983-A601-462B2B4FC145Q36523046-ACB1E395-3DFD-4329-A655-18C864ED5C2FQ36617963-2D693EDF-FF1F-451F-B9D2-01F41D5DC256
P2860
Selection of Plasmodium falciparum pfmdr1 alleles following therapy with artemether-lumefantrine in an area of Uganda where malaria is highly endemic
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
name
Selection of Plasmodium falcip ...... here malaria is highly endemic
@ast
Selection of Plasmodium falcip ...... here malaria is highly endemic
@en
Selection of Plasmodium falcip ...... here malaria is highly endemic
@nl
type
label
Selection of Plasmodium falcip ...... here malaria is highly endemic
@ast
Selection of Plasmodium falcip ...... here malaria is highly endemic
@en
Selection of Plasmodium falcip ...... here malaria is highly endemic
@nl
prefLabel
Selection of Plasmodium falcip ...... here malaria is highly endemic
@ast
Selection of Plasmodium falcip ...... here malaria is highly endemic
@en
Selection of Plasmodium falcip ...... here malaria is highly endemic
@nl
P2860
P50
P921
P1476
Selection of Plasmodium falcip ...... here malaria is highly endemic
@en
P2093
Christian Dokomajilar
Samuel L Nsobya
P2860
P304
P356
10.1128/AAC.50.5.1893-1895.2006
P407
P577
2006-05-01T00:00:00Z